Physician profile
Beth Thompson
NPI 1346934130
$776.64
in general payments reported to CMS, 2019-2025
13 companies · $359 in 2025
The $359 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $153 · 2024: $264 · 2025: $359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $777.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $776.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $325.58 | 2023-2025 | Farxiga, Airsupra |
| Abbvie INC. | $158.10 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $62.54 | 2024 | Jardiance |
| Shield Therapeutics INC | $50.94 | 2023-2024 | Accrufer |
| Sumitomo Pharma America, INC. | $34.10 | 2024-2025 | Gemtesa |
| Lexicon Pharmaceuticals, INC. | $24.57 | 2023 | Inpefa |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.65 | 2024 | Relistor |
| Daiichi Sankyo INC. | $19.62 | 2023 | Injectafer |
| Si-Bone, INC. | $19.26 | 2025 | |
| Janssen Pharmaceuticals, INC | $17.82 | 2024 | Xarelto |
| Scpharmaceuticals INC. | $15.60 | 2024 | |
| Phathom Pharmaceuticals, INC. | $14.93 | 2024 | Voquezna |
| Vifor Pharma, INC. | $12.93 | 2023 | Veltassa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beth Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.